유방의 화생성 편평상피세포암종 17예에 대한 임상 및 병리학적 분석 = Metaplastic Squamous Carcinoma of the Breast: Clinicopathologic Analysis of 17 Cases

다국어 초록 (Multilingual Abstract)

Background : Squamous cell carcinoma of the breast is very rare and it is considered to arise from metaplastic change of ductal carcinoma. Metaplastic squamous cell carcinoma (MSC) of the breast includes pure squamous cell carcinoma, metaplastic adenosquamous carcinoma and low grade adenosquamous carcinoma. Most of the cases of MSC of the breast were reported to have lymph node metastasis and this has a worse prognosis than that of conventional invasive ductal carcinoma. Methods : We collected 17 cases of MSC of the breast from 1,173 cases of breast cancer and analyzed the clinicopathological characteristics. Results : The age range was 31 to 69 years (mean age: 47.2). The mean tumor size was 3.6 cm. Twelve cases (70.6%) had a negative nodal status. The majority of the cases were of a high nuclear grade (grade III: 76.5%), and a high histologic grade (grade III: 88.2%). All the cases had no amplification of HER2, and they were negative for hormonal receptors, except for 2 cases with weak positivity. All the cases showed positivity for EGFR (3+: 14 cases, 1+: 3 cases). Clinical relapse was found in 3 patients on follow up and two of them expired due to lung and bone
metastasis. Conclusions : MSC is associated with high nuclear and istologic grades, a high EGFR expression and they are triple negative for ER, PR, and HER2. The EGFR immunopositivity of MSC suggests a basal-like subtype.

다국어 초록 (Multilingual Abstract)

Background : Squamous cell carcinoma of the breast is very rare and it is considered to arise from metaplastic change of ductal carcinoma. Metaplastic squamous cell carcinoma (MSC) of the breast includes pure squamous cell carcinoma, metaplastic adenosquamous carcinoma and low grade adenosquamous carcinoma. Most of the cases of MSC of the breast were reported to have lymph node metastasis and this has a worse prognosis than that of conventional invasive ductal carcinoma. Methods : We collected 17 cases of MSC of the breast from 1,173 cases of breast cancer and analyzed the clinicopathological characteristics. Results : The age range was 31 to 69 years (mean age: 47.2). The mean tumor size was 3.6 cm. Twelve cases (70.6%) had a negative nodal status. The majority of the cases were of a high nuclear grade (grade III: 76.5%), and a high histologic grade (grade III: 88.2%). All the cases had no amplification of HER2, and they were negative for hormonal receptors, except for 2 cases with weak positivity. All the cases showed positivity for EGFR (3+: 14 cases, 1+: 3 cases). Clinical relapse was found in 3 patients on follow up and two of them expired due to lung and bone
metastasis. Conclusions : MSC is associated with high nuclear and istologic grades, a high EGFR expression and they are triple negative for ER, PR, and HER2. The EGFR immunopositivity of MSC suggests a basal-like subtype.

참고문헌 (Reference)

1 김동훈, "인체 유방암종에서 p34cdc2, p27Kip1, p21WAF1/Cip1 및 p53의 발현" 대한병리학회 39 (39): 391-400, 2005

2 최승혜, "유방의 화생성 편평세포암종" 대한외과학회 64 (64): 170-174, 2003

3 Dent R, "Triple-negative breast cancer:clinical features and patterns of recurrence" 13 : 4429-4434, 2007

4 Park JH, "The clinicopathologic characteristics of 38 metaplastic carcinomas of the breast" 8 : 59-63, 2005

5 Sentani K, "Synchronous squamous cell carcinoma of the breast and invasive lobular carcinoma" 115 : 1422-1425, 2007

6 Shigekawa T, "Squamous cell carcinoma of the breast in the form of an intracystic tumor" 14 : 109-112, 2007

7 Aparicio I, "Squamous cell carcinoma of the breast" 137 : 222-226, 2008

8 Hayes MM, "Squamous cell carcinoma in situ of the breast: a light microscopic and immunohistochemical study of a previously undescribed lesion" 31 : 1414-1419, 2007

9 Bossuyt V, "Remarkably high frequency of EGFR expression in breast carcinomas with squamous differentiation" 13 : 319-327, 2005

10 Allred DC, "Prognostic and predictive factors in breast cancer by immunohistochemical analysis" 11 : 155-168, 1998

11 Lee KG, "Primary squamous cell carcinoma of the breast" 29 : 1114-1118, 1997

12 Tavassoli FA, "Pathology and genetics of tumours of the breast and female genital organs. World Health Organization classification of tumours" IARC press 37-40, 2003

13 Tse GM, "P63 is useful in the diagnosis of mammary metaplastic carcinomas" 38 : 16-20, 2006

14 Koker MM, "P63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma" 28 : 1506-1512, 2004

15 Wargotz ES, "Metaplastic carcinomas of the breast: IV. squamous cell carcinoma of ductal origin" 65 : 272-276, 1990

16 Abboud B, "Metaplastic carcinoma of the breast: case report of a sarcomatoid type and literature review" 51 : 234-237, 2003

17 Tse GM, "Metaplastic carcinoma of the breast: a clinicopathological review" 59 : 1079-1083, 2006

18 Luini A, "Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the EuropeanI nstitute of Oncology and review of the literature" 101 : 349-353, 2007

19 Huvos AG, "Metaplastic breast carcinoma:rare form of mammary carcinoma" 73 : 1078-1082, 1973

20 Barnes P, "Metaplastic breast carcinoma:clinical-pathologic characteristics and HER2/neu expression" 91 : 173-178, 2005

21 Kochhar R, "Metaplastic breast carcinoma with squamous differentiation: molecular and clinical analysis of six cases" 11 : 367-369, 2005

22 Rayson D, "Metaplastic breast cancer: prognosis and response to systemic therapy" 10 : 413-419, 1999

23 Rosen PP, "Low-grade adenosquamous carcinoma: a variant of metaplastic mammary carcinoma" 11 : 351-358, 1987

24 Robbins P, "Histologic grading of breast carcinomas: a study of interobserver agreement" 26 : 873-879, 1995

25 Kersting C, "Gene dosage PCR and fluorescence in situ hybridization reveal low frequency of EGFR amplifications despite protein overexpression in invasive breast carcinoma" 84 : 582-587, 2004

26 Hirsch FR, "Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis" 21 : 3798-3807, 2003

27 Normanno N, "Epidermal growth factor receptor (EGFR) signaling in cancer" 366 : 2-16, 2006

28 Tot T, "Eccrine ductal and acrosyringeal differentiation of the breast epithelium: a lesion associated with some metaplastic breast carcinomas" 449 : 565-571, 2006

29 Reis-Filho JS, "EGFR amplification and lack of activating mutations in metaplastic breast carcinomas" 209 : 445-453, 2006

30 The Korean Breast Cancer Society, "Clinical characteristics of Korean breast cancer patients in 1998" 15 : 569-579, 2000